Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAFIa plasma kinetics in acute ischemic stroke
2017-002760-41Phase 2Completed
- Sponsor
- Servier
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Servier. Primary endpoint: Systemic TAFIa plasma level assessment. Started Aug 2017; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2017-002760-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002760-41.